Fig. 3: Associations of baseline and longitudinal changes in plasma AD-related biomarkers with longitudinal changes in brain volume. | Molecular Psychiatry

Fig. 3: Associations of baseline and longitudinal changes in plasma AD-related biomarkers with longitudinal changes in brain volume.

From: Associations between trajectories of plasma biomarkers for Alzheimer’s disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank

Fig. 3

Panel A demonstrates the association between baseline plasma levels and cortical and subcortical volume changes, while panel B illustrates the association between changes in plasma levels over time and corresponding changes in cortical and subcortical volumes (*FDR-corrected P < 0.05). Beta-coefficients (95% confidence intervals) were derived from the linear mixed effects-models that were adjusted for sex, age, ethnicity, townsend deprivation index, assessment center, smoking status, alcohol use, APOE ε4 allele, hypertension, diabetes, cardiovascular arterial disease, history of COVID-19 infection, and total intracranial volume. Aβ amyloid-β, GFAP glial fibrillary acidic protein, NfL neurofilament light chain, p-tau181, phosphorylated tau 181.

Back to article page